Dr. Channick is a professor of medicine, Co-Director of the Vascular Disease Program, the Saul Brandman Endowed Chair in Pulmonary Arterial Hypertension, and Director of the Acute and Chronic Thromboembolic Disease Program at the David Geffen School of Medicine at UCLA. He has over 25 years of experience in pulmonary vascular disease and has contributed to the development of multiple FDA-approved therapies. He provides strategic guidance on clinical development and trial design.